Management of sickle cell disease in patients undergoing cardiac surgery

Todd C Crawford; Michael V Carter; Rina K Patel; Alejandro Suarez-Pierre; Sophie Z Lin; Jonathan Trent Magruder; Joshua C Grimm; Duke E Cameron; William A Baumgartner; Kaushik Mandal

doi:10.1111/jocs.13093

Management of sickle cell disease in patients undergoing cardiac surgery

J Card Surg. 2017 Feb;32(2):80-84. doi: 10.1111/jocs.13093. Epub 2017 Jan 16.

Affiliations

¹ Division of Cardiac Surgery Baltimore, Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland.
² Division of Hematology, Department of Medicine, Greater Baltimore Medical Center, Baltimore, Maryland.

PMID: 28093814
DOI: 10.1111/jocs.13093

Abstract

Sickle cell disease is a life-limiting inherited hemoglobinopathy that poses inherent risk for surgical complications following cardiac operations. In this review, we discuss preoperative considerations, intraoperative decision-making, and postoperative strategies to optimize the care of a patient with sickle cell disease undergoing cardiac surgery.

Publication types

Review

MeSH terms

Adult
Anemia, Sickle Cell / complications
Anemia, Sickle Cell / therapy*
Atrial Fibrillation / complications
Atrial Fibrillation / surgery
Blood Transfusion / methods*
Cardiac Surgical Procedures*
Disease Management*
Heart Failure / complications*
Heart Failure / surgery
Humans
Male
Preoperative Care / methods*